EU Investigates German Pharma Companies

barbara.lempert State aid: Commission opens in-depth inquiry into alleged aid to German pharmaceutical companies in financial difficulties Brussels, 24 July 2013 – The ...

Pharma companies continue to flourish in Ireland

mia.burns By Mia Burns Ireland has achieved global recognition as a center of excellence within the life sciences industry. According to IDA Ireland, 9 of the 10 top global pharma ...

Teva Pharma CEO bets on Alzheimer’s, CNS research amid major reboot

Ryan McBride Teva Pharmaceutical CEO Jeremy Levin has highlighted another tactic to his company's revamped strategy to deliver new medicines as older brands face generic drug competition: ...

China detains first U.S. citizen in pharma industry probe

Tracy Staton The Chinese pharma crackdown just keeps on widening. Now, a U.S. citizen has been detained in connection with the corruption probe, Reuters reports. And two more ...

Pharma Has A “Lot Of Exposure” In China: Ted Explains

esilverman Over the past few weeks, the bribery scandal in China that is enveloping GlaxoSmithkline has caused a stir. The episode comes less than a year after the drugmaker ...

Isis Pharma fuels fervor for cardio drug with more midstage data

Ryan McBride Isis Pharmaceuticals has revealed more enticing details about its midstage program for a blood fat-lowering drug. After wowing investors with data from a Phase II study ...

Report: Big Pharma mounts secret attack against data transparency rule

John Carroll While Big Pharma's two big trade groups on both sides of the Atlantic have mounted a vigorous counterattack against proposed European rules requiring companies to open ...

Pharma Enlists Patients To Prevent The Release Of Clinical Trial Data

esilverman The pharmaceutical industry is quietly working on a concerted, behind-the-scenes effort to prevent the release of clinical trial data, a flashpoint of controversy ...

IMS-Appature Appoints Pharma Industry Business Development Veteran

mia.burns Betty Michelson as New Sales Solution Executive   June 19, 2013 (Seattle, WA)  –  IMS-Appature Inc. (www.appature.com), the provider of Appature Nexus, the leading ...

U.K. pharma group’s cannabis-based diabetes drug sparks insulin output

Ryan McBride GW Pharmaceuticals has expanded mindsets about potential diabetes treatment. In a small midstage study of patients on its pot-based drug candidate, the U.K. drug developer ...

Pharma market in Poland set to rebound in 2013

mia.burns In 2012, the pharmacy market in Poland has recorded negative growth for the first time in many years and fell 6% year on year. These developments were mostly driven by the ...

After Eylea win, Regeneron Pharma execs puzzle over R&D scale-up challenge

Ryan McBride With a new blockbuster drug and more potential hits in development, Regeneron Pharmaceuticals has been successful long enough for top executives to consider the challenges ...
Page 10 of 17« First...89101112...Last »
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS